2016 Internatinal Meeting o the Molecular Biology of Hepatitis B Viruses

 说明(申请人提供)：在这份提案中，我们申请资助青年科学家参加2016年9月21日至24日在韩国首尔延世大学会议设施举行的2016国际乙肝病毒分子生物学会议的旅费。这次会议是聚集关注乙肝病毒(乙肝病毒)和密切相关的丁型肝炎病毒(HDV)的国际研究人员的唯一论坛。世界上大约25%的人口感染了乙肝病毒。不幸的是，尽管有预防性疫苗可用，但全球范围内仍有许多新感染病例发生，主要是由于成本和其他问题导致疫苗未得到充分利用。此外，对于已经慢性感染乙肝病毒的约3.5亿人(其中约1500万人同时感染丁型肝炎病毒)，疫苗没有治疗价值。因此，全世界每年有50万至100万人死于乙肝病毒/HDV。因此，必须继续进行关于乙肝病毒的基础研究，并及时讨论和传播该领域的最新进展。一年一度的乙肝会议为科学交流和传播最新研究信息提供了论坛。2014年的会议将坚持和加强传统的形式。它将包括8个口头科学会议和2个海报会议，以及较少结构的“网络”时间。科学互动将通过两个主旨演讲(见他们的录取通知书)来促进。与以往一样，已作出巨大努力将会议费用降至最低。此外，自2005年以来，乙肝基金会一直坚定地承诺支持这次会议，为会议的组织提供一个永久的住所，并让其工作人员监督会议和宣传会议，特别是对少数族裔人数较少的大学。为了允许初级调查人员和少数族裔调查人员参与，要求国家卫生研究院提供支持，以帮助支付会议费用。预计将有超过200-300名与会者登记参加2016年乙肝会议，这将标志着乙肝会议32周年。

 DESCRIPTION (provided by applicant): In this proposal, we request for funding to support the travel expenses for young scientists to attend and participate in the 2016 International Meeting on the Molecular Biology of Hepatitis B Viruses, scheduled for September 21st-24th, 2016 at the conference facility of the Yonsei University of Seoul, South Korea. This meeting is the only forum that gathers the international community of researchers that focus on the hepatitis B virus (HBV) and the closely associated hepatitis delta virus (HDV). Approximately 25% of the world's population has been infected by HBV. Unfortunately, despite the availability of prophylactic vaccines, many new infections occur worldwide, mostly because of underutilization of the vaccine due to cost and other issues. Moreover, for the approximately 350 million people already chronically infected with HBV (approximately 15 million of whom are co-infected with HDV), the vaccine is of no therapeutic value. As a result, between 0.5 and 1 million people die of HBV/HDV every year worldwide. It is therefore imperative that basic research on HBV continues, and the latest progress in the field is discussed and disseminated in a timely manner. The annual HBV meeting provides the forum for scientific exchanges and the dissemination of latest research information. The 2014 meeting will uphold and enhance the traditional format. It will consist of 8 oral scientific sessions and 2 poster sessions as well as less structured "networking" time. The scientific interactions will be facilitated by two keynote addresses (see their acceptance letters). As in the past, great effort has been made to minimize the cost of the meeting. Furthermore, the Hepatitis B Foundation has made a strong commitment to support this meeting since 2005, in terms of providing a permanent home for organizing the meeting and making its staff available for supervising the meeting and publicizing it, especially to universitis with large numbers of underrepresented minorities. In order to allow the participation of junior and minority investigators, support from the NIH to help defray the meeting costs is requested. It is expected that over 200-300 attendees will register for the 2016 HBV meeting, which will mark the 32nd anniversary of the HBV meeting.